Search Results

KP's physicians would be involved in developing a "platform" to offer Geisinger and other health systems its value-based care expertise, including in design of care models, pharmacy practices, consumer digital engagement.

Out-of-network price benchmarking through government regulation, competition with Medicare fee-for-service, and the fact that insurers actually bear risk in the MA market may drive down prices in MA.

While 70% of hospitals are compliant with the federal price transparency rule, the feds have sent more than 900 warning letters to hospitals about their posted data, with four hospitals fined for non-compliance.

Patients with early Alzheimer's disease who took lecanemab in a major clinical trial declined an average of five months slower than other subjects over an 18-month period.

While Biden's proposed regs on short-term plans are likely to go into effect this year or early next, the House-passed CHOICE Arrangement Act – a "cash for coverage" option — is unlikely to win favor in the Senate.

Since many people don't use statins, vaccines, or COVID-19 therapies, and many choose to smoke cigarettes and eat the wrong food, life expectancy has dropped in the U.S., says the FDA commissioner.

Opioid manufacturers and distributors are paying more than $54 billion in restitution to settle lawsuits about their role in the overdose epidemic, with little oversight on how the money is spent.

Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, while some insurers are bypassing hospital pharmacies and physician offices and instead sending more complex drugs through third-party pharmacies.